CC
RXDX

Commodore Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Commodore Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-127,156
Closed -$13.6M – 34
2023
Q1 		$13.6M Hold
127,156
– – 2.08% 19
2022
Q4 		$14M Buy
+127,156
New +$14M 2.11% 17